Sr. Manager, Tax Technology at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

8+ Years with BS/BA or 6+ Years with MS/MA or MBA
8+ years of relevant experience in tax operations or tax technology
3+ years in a global publicly traded corporate tax department
Strong working experience with data including a solid understanding of data structures, data integrity, and the ability to troubleshoot data-related problems
Strong process improvement and business process design
Advanced experience with Microsoft Suite including Excel, Visio, and Teams

Responsibilities

Partner with Tax SMEs to understand current-state processes and identify opportunities for improvement
Design future-state processes that are scalable, repeatable, and auditable, with a focus on operational efficiency, data integrity, and data readiness
Document processes and controls such that an Analyst can execute the process as well as to support internal and external audit requirements
Establish and enforce technical standards, best practices, and internal control requirements (including SOX compliance)
Maintain processes including deploying enhancements as business data changes or tax requirements evolve
Communicate effectively with stakeholders on financial systems governance and tax related matters

Skills

Tax Technology

Tax Reporting

Process Design

Workflow Automation

Transfer Pricing

International Tax

Federal Tax

State Tax

Local Tax

Audit Compliance

Process Improvement

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free